NL-OMON49007
Recruiting
Not Applicable
REvascularization versus optimal medical therapy on left Ventricular ISchemia reduction: Exploring the associations between ischemia, functional outcome and collaterals in the treatment of Chronic Total Occlusion patients - REVISE-CTO
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 82
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. A chronic total occlusion is present and target lesion. A CTO is required to
- •meet the following characteristics:
- •A 100% luminal narrowing of the coronary artery without antegrade flow, i.e.
- •Thrombolysis in Myocardial Infarction flow grade 0 or 1;
- •Older than 3 months, established with previous PCI or with angiographic
- •characteristics;
- •Amenable to percutaneous revascularization.
- •2\. Patient has a clinical indication to perform CTO PCI.
- •3\. A SPECT is performed at baseline to assess ischemia and a cardiac magnetic
- •resonance imaging (CMR) scan to assess viability, as part of routine patient
Exclusion Criteria
- •Subject is younger than 18 years of age;
- •Persistent or permanent atrial fibrillation;
- •Presence of a non\-MRI compatible cardiac device, i.e. pacemaker or
- •implantable cardioverter defibrillator;
- •Body weight \> 250 kg;
- •Unable to exert, i.e. due to physical disability;
- •Any contraindication for SPECT or CMR, i.e. cerebrovascular clips,
- •claustrophobia;
- •Known renal insufficiency (estimated Glomerular Filtration Rate \[eGFR] \<60
- •mL/min/1\.73m2 or serum creatinine level of \>2\.5 mg/dL or subject on dialysis);
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Revascularization versus Medical Treatment in Patients with Ischemic Left Ventricular dysfunctioDiseases of the circulatory systemKCT0008380Samsung Medical Center900
Completed
Not Applicable
Clinical Outcomes Utilising Revascularisation and Aggressive Drug EvaluatioISRCTN18172323Department of Veteran Affairs, U.S. Federal Government and McMaster University Faculty of Health Sciences (Canada)2,546
Recruiting
Not Applicable
Complete revascularization versus culprit lesion only PCI in NSTEMInon-ST-elevation myocardial infarction (NSTEMI)Multivessel coronary artery diseaseI21.4I25.12I25.13Acute subendocardial myocardial infarctionDRKS00031653eipzig Heart Science gGmbH3,390
Completed
Not Applicable
Rescue angioplasty versus conservative treatment or repeat thrombolysis (the REACT trial)Myocardial infarctionCirculatory SystemIschaemic heart diseasesISRCTN31931021British Heart Foundation (UK)
Terminated
Phase 3
Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event ReductionHeart-lung Transplant RejectionNCT01795729Assistance Publique - Hôpitaux de Paris6